- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x USG: 4-(4-benzyl-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one(Non-covalent)
- 30 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 5 residues within 4Å:- Chain A: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.4: 6 residues within 4Å:- Chain A: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.5: 8 residues within 4Å:- Chain A: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.6: 8 residues within 4Å:- Chain A: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.7
Ligand excluded by PLIPGOL.7: 7 residues within 4Å:- Chain A: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.1, GOL.6
Ligand excluded by PLIPGOL.10: 5 residues within 4Å:- Chain B: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.12: 6 residues within 4Å:- Chain B: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.13: 8 residues within 4Å:- Chain B: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.14: 8 residues within 4Å:- Chain B: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.15
Ligand excluded by PLIPGOL.15: 7 residues within 4Å:- Chain B: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.9, GOL.14
Ligand excluded by PLIPGOL.18: 5 residues within 4Å:- Chain C: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.20: 6 residues within 4Å:- Chain C: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.21: 8 residues within 4Å:- Chain C: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.22: 8 residues within 4Å:- Chain C: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.23
Ligand excluded by PLIPGOL.23: 7 residues within 4Å:- Chain C: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.17, GOL.22
Ligand excluded by PLIPGOL.26: 5 residues within 4Å:- Chain D: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.28: 6 residues within 4Å:- Chain D: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.29: 8 residues within 4Å:- Chain D: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.30: 8 residues within 4Å:- Chain D: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.31
Ligand excluded by PLIPGOL.31: 7 residues within 4Å:- Chain D: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.25, GOL.30
Ligand excluded by PLIPGOL.34: 5 residues within 4Å:- Chain E: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.36: 6 residues within 4Å:- Chain E: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.37: 8 residues within 4Å:- Chain E: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.38: 8 residues within 4Å:- Chain E: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.39
Ligand excluded by PLIPGOL.39: 7 residues within 4Å:- Chain E: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.33, GOL.38
Ligand excluded by PLIPGOL.42: 5 residues within 4Å:- Chain F: I.288, T.418, A.419, F.420, E.421
Ligand excluded by PLIPGOL.44: 6 residues within 4Å:- Chain F: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.45: 8 residues within 4Å:- Chain F: P.92, G.93, R.328, G.329, Y.330, A.331, A.411, D.413
Ligand excluded by PLIPGOL.46: 8 residues within 4Å:- Chain F: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.47
Ligand excluded by PLIPGOL.47: 7 residues within 4Å:- Chain F: F.44, D.46, F.47, S.103, F.104
- Ligands: USG.41, GOL.46
Ligand excluded by PLIP- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.3: 7 residues within 4Å:- Chain A: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.289
PEG.11: 7 residues within 4Å:- Chain B: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:T.289
PEG.19: 7 residues within 4Å:- Chain C: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:T.289
PEG.27: 7 residues within 4Å:- Chain D: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.293
PEG.35: 7 residues within 4Å:- Chain E: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:D.293
PEG.43: 7 residues within 4Å:- Chain F: L.261, H.269, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:D.293
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.8: 4 residues within 4Å:- Chain A: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.16: 4 residues within 4Å:- Chain B: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.24: 4 residues within 4Å:- Chain C: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.32: 4 residues within 4Å:- Chain D: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.40: 4 residues within 4Å:- Chain E: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.48: 4 residues within 4Å:- Chain F: T.289, H.290, Q.417, T.418
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x USG: 4-(4-benzyl-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one(Non-covalent)
- 30 x GOL: GLYCEROL(Non-functional Binders)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA